Company
ZELTIQ™, founded in 2005, is a science-based medical device company dedicated to the development and commercialization of non-invasive procedures to help patients achieve cosmetic improvements by reducing or modifying unwanted fat. The CoolSculpting™ by ZELTIQ procedure utilizes a novel technology called Cryolipolysis™ (the use of controlled cooling to remove fat). ZELTIQ has licensed all commercial development rights from Massachusetts General Hospital and is continuing evaluation and development with leading aesthetic research centers.
The CoolSculpting procedure for non-invasive fat layer reduction is available in Canada, the European Union and other international markets. The device is cleared by the FDA in the United States for various applications related to skin cooling during dermatologic treatments, with a pending application for non-invasive body fat reduction.
Click here to learn more about ZELTIQ.
